Oncolytic Viruses on Drugs: Achieving Higher Therapeutic Efficacy
- 28 August 2018
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 4 (10) , 1448-1467
Abstract
No abstract availableKeywords
This publication has 165 references indexed in Scilit:
- Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcomaInternational Journal of Cancer, 2014
- Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGFInternational Journal of Cancer, 2014
- Enhanced killing of therapy‐induced senescent tumor cells by oncolytic measles vaccine virusesInternational Journal of Cancer, 2013
- Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell DeathCancer Cell, 2011
- Case series of 226 γ-hydroxybutyrate–associated deaths: lethal toxicity and traumaThe American Journal of Emergency Medicine, 2011
- Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replicationInternational Journal of Cancer, 2010
- Non‐conventional signal transduction by type 1 interferons: The NF‐κB pathwayJournal of Cellular Biochemistry, 2007
- Effects of tumor selective replication-competent herpes viruses in combination with gemcitabine on pancreatic cancerCancer Chemotherapy and Pharmacology, 2007
- Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferationVirchows Archiv, 2006
- Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5‐fluorouracil and surgical resection in peritoneal cancer dissemination modelsThe Journal of Gene Medicine, 2005